(Q34984114)

5 August 2017

1 reference

title

Treatment of patients with hepatitis C and cirrhosis (English)

1 reference

5 August 2017

0 references

1 reference

Teresa L Wright

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

5 Suppl 1

1 reference

5 August 2017

page(s)

S185-94

1 reference

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.36812

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.36812

1 reference

5 August 2017

1 reference